53 related articles for article (PubMed ID: 30861043)
21. Raman Microscopy: Progress in Research on Cancer Cell Sensing.
Elumalai S; Managó S; De Luca AC
Sensors (Basel); 2020 Sep; 20(19):. PubMed ID: 32992464
[TBL] [Abstract][Full Text] [Related]
22. Discrimination of different cancer types clustering Raman spectra by a super paramagnetic stochastic network approach.
González-Solís JL
PLoS One; 2019; 14(3):e0213621. PubMed ID: 30861043
[TBL] [Abstract][Full Text] [Related]
23. Raman spectroscopy combined with multivariate statistical algorithms for the simultaneous screening of cervical and breast cancers.
Cao Y; Xiong J; Du Y; Tang Y; Yin L
Lasers Med Sci; 2024 Feb; 39(1):68. PubMed ID: 38374512
[TBL] [Abstract][Full Text] [Related]
24. Discrimination of leukemias and non-leukemic cancers in blood serum samples of children and adolescents using a Raman spectral model.
Lima AMF; Daniel CR; Pacheco MTT; de Brito PL; Silveira L
Lasers Med Sci; 2022 Dec; 38(1):22. PubMed ID: 36564570
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer detection based on serum sample surface enhanced Raman spectroscopy.
Vargas-Obieta E; Martínez-Espinosa JC; Martínez-Zerega BE; Jave-Suárez LF; Aguilar-Lemarroy A; González-Solís JL
Lasers Med Sci; 2016 Sep; 31(7):1317-24. PubMed ID: 27289243
[TBL] [Abstract][Full Text] [Related]
26. Quantitative detection of the human cervical cancer oncogene for monitoring the minimal residual disease in acute leukemia.
Qiao SK; Guo XN; Ren JH; Zhang JN; Wang Y
Exp Biol Med (Maywood); 2015 Jan; 240(1):128-34. PubMed ID: 25034723
[TBL] [Abstract][Full Text] [Related]
27. Monitoring of chemotherapy leukemia treatment using Raman spectroscopy and principal component analysis.
González-Solís JL; Martínez-Espinosa JC; Salgado-Román JM; Palomares-Anda P
Lasers Med Sci; 2014 May; 29(3):1241-9. PubMed ID: 24407964
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancer detection based on serum sample Raman spectroscopy.
González-Solís JL; Martínez-Espinosa JC; Torres-González LA; Aguilar-Lemarroy A; Jave-Suárez LF; Palomares-Anda P
Lasers Med Sci; 2014 May; 29(3):979-85. PubMed ID: 24197519
[TBL] [Abstract][Full Text] [Related]
29. A method to identify new molecular markers for assessing minimal residual disease in acute leukemia patients.
Jancuskova T; Plachy R; Stika J; Zemankova L; Hardekopf DW; Liehr T; Kosyakova N; Cmejla R; Zejskova L; Kozak T; Zak P; Zavrelova A; Havlikova P; Karas M; Junge A; Ramel C; Pekova S
Leuk Res; 2013 Oct; 37(10):1363-73. PubMed ID: 23870092
[TBL] [Abstract][Full Text] [Related]
30. Incidence of acute myeloid leukemia after breast cancer.
Valentini CG; Fianchi L; Voso MT; Caira M; Leone G; Pagano L
Mediterr J Hematol Infect Dis; 2011; 3(1):e2011069. PubMed ID: 22220266
[TBL] [Abstract][Full Text] [Related]
31. Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status.
Ha SA; Lee YS; Shin SM; Kim HK; Kim S; Namkoong H; Kim HJ; Jung SM; Lee YS; Chung YJ; Jung SS; Kim JW
BMC Cancer; 2009 Feb; 9():51. PubMed ID: 19208263
[TBL] [Abstract][Full Text] [Related]
32. Raman spectroscopy and multivariate analysis of serum samples from breast cancer patients.
Pichardo-Molina JL; Frausto-Reyes C; Barbosa-García O; Huerta-Franco R; González-Trujillo JL; Ramírez-Alvarado CA; Gutiérrez-Juárez G; Medina-Gutiérrez C
Lasers Med Sci; 2007 Nov; 22(4):229-36. PubMed ID: 17297595
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
